{"id":"W2160134481","doi":"10.1016/s2213-2600(14)70201-2","title":"Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study","year":2014,"lang":"en","type":"article","venue":"The Lancet Respiratory Medicine","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":484,"is_retracted":false,"has_abstract":false,"ca_institutions":"Gilead Sciences (Canada)","funders":"MedImmune; European Respiratory Society","keywords":"Benralizumab; Medicine; Mepolizumab; Asthma; Placebo; Internal medicine; Population; Exacerbation; Eosinophilic; Dose-ranging study; Sputum; Immunology; Eosinophil; Gastroenterology; Tuberculosis; Double blind; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002249154,0.002578531,0.00537659,0.0006918682,0.0004948676,0.001498761,0.00158294,0.003254839,0.006842634],"category_scores_gemma":[0.001980924,0.001204028,0.003193145,0.0004672006,0.001745779,0.001628796,0.0005840448,0.004118461,0.00147599],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009061538,"about_ca_system_score_gemma":0.0006749369,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001263945,"about_ca_topic_score_gemma":0.001840299,"domain_scores_codex":[0.9990339,0.0004848229,0.00005666557,0.0001883431,0.00007707208,0.0001591566],"domain_scores_gemma":[0.9987729,0.0004937291,0.0002299109,0.0001201593,0.00007716681,0.0003060693],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9871933,0.003700698,0.0001702109,0.000441551,0.0006124918,0.00002298336,0.00002642061,0.0001715128,0.0021824,0.00004078168,0.0002398334,0.005197746],"study_design_scores_gemma":[0.9598172,0.03841523,0.0007555816,0.00002195898,0.0003298946,0.00001458553,0.00001553973,0.0001280608,0.0001879549,0.00006914331,0.0002328023,0.00001197711],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9810781,0.01087299,0.0007126329,0.0007927826,0.001160424,0.00225096,0.0009973433,0.0001386167,0.001996144],"genre_scores_gemma":[0.9808683,0.00521465,0.001540498,0.001744798,0.0009753426,0.002822868,0.001033733,0.00006220843,0.005737694],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006842634,"threshold_uncertainty_score":0.02289093,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05700244567622967,"score_gpt":0.383372086142058,"score_spread":0.3263696404658284,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}